FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064131 [Registered on: 14/03/2024] Trial Registered Prospectively
Last Modified On: 25/01/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Other 
Public Title of Study   A comparative study of 0.5% ropivacaine with combination of 0.5% bupivacaine and 2% lidocaine on intraocular pressure before and after peribulbar block in cataract surgery 
Scientific Title of Study   A comparative study of efficacy and safety of single drug 0.5% Ropivacaine on intraocular pressure before and after peribulbar block in cataract surgery with most commonly used mixture of 0.5% bupivacaine and 2% lidocaine with adrenaline : A randomised clinical trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rekha R Mudhol 
Designation  Professor and hod department of ophthalmology 
Affiliation  BLDE(DU)Shri B M Patil Medical College Hospital and Research Centre 
Address  Room number-1, Department of Ophthalmology, BLDE(DU)Shri B M Patil Medical College Hospital and Research Centre, BANGARAMMA SAJJAN Campus, Vijayapura

Bijapur
KARNATAKA
586103
India 
Phone  9449938997  
Fax    
Email  rekhamudhol@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sneha 
Designation  2nd year PG, department of ophthalmology 
Affiliation  SHRI B.M.PATIL MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE 
Address  Room number-13, Department of Ophthalmology, BLDE(DU)Shri B M Patil Medical College Hospital and Research Centre, BANGARAMMA SAJJAN Campus, Vijayapura

Bijapur
KARNATAKA
586103
India 
Phone  9490941909  
Fax    
Email  snehachowdary972@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rekha R Mudhol 
Designation  Professor and hod department of ophthalmology 
Affiliation  SHRI B.M.PATIL MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE 
Address  Room number-13, Department of Ophthalmology, BLDE(DU)Shri B.M. Patil Medical College Hospital and Research Centre, BANGARAMMA SAJJAN Campus, Vijayapura

Bijapur
KARNATAKA
586103
India 
Phone  9449938997  
Fax    
Email  rekhamudhol@gmail.com  
 
Source of Monetary or Material Support  
BLDE(DU)Shri B.M. Patil Medical College Hospital and Research Centre, Vijayapura 
 
Primary Sponsor  
Name  BLDE 
Address  Shri B M Patil Medical College Hospital and Research Centre Bangaramma sajjan campus Vijayapura 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rekha R Mudhol  BLDE(DU) Shri B M Patil Medical College Hospital and Research Centre  Room number -13, Department of Ophthalmology, BANGARAMMA SAJJAN campus, Vijayapura-586103
Bijapur
KARNATAKA 
9449938997

rekhamudhol@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
BLDE Deemed to be University Vijayapura  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  SENILE IMMATURE CATARCT 
Patients  (1) ICD-10 Condition: H251||Age-related nuclear cataract, (2) ICD-10 Condition: H251||Age-related nuclear cataract,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Injection ropivacaine 0.5%  In one group - 8ml injection ropivacaine 0.5% as local anesthesia in peribulbar block in cataract surgery 
Comparator Agent  Mixture of 0.5% bupivacaine and 2% lidocaine injections   In one group - mixture of 4ml injection bupivacaine 0.5% and 4ml injection lignocaine 2% as local anesthesia in peribulbar block in cataract surgery 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1)Uncomplicated cataract.
2)Normal intraocular pressure 
 
ExclusionCriteria 
Details  1)Patients with cognitive impairment.
2)Patients allergic to hyaluronidase, lidocaine, ropivacaine and bupivacaine.
3)Any other surgeries combined with cataract.
4)Patients with hypertension and coronary artery disease in lignocaine group.
 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
1)The study will help us to study the adverse effects caused by raised intra ocular pressure post peribulbar block and reduce the side effects caused by prolonged motor blockade by using a low concentrated anesthetic.

2)This study will help us to know an ideal drug for peribulbar block with minimal complications.
 
31 cases in 6months and total 62 cases in 1 year
 
 
Secondary Outcome  
Outcome  TimePoints 
This study will help us to know an ideal drug for peribulbar block with minimal complications.
 
31 cases in 6months and total 62 cases in 1 year
 
 
Target Sample Size   Total Sample Size="62"
Sample Size from India="62" 
Final Enrollment numbers achieved (Total)= "62"
Final Enrollment numbers achieved (India)="62" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   21/03/2024 
Date of Study Completion (India) 14/10/2024 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
In process, Submitting BLDE JOURNAL OF HEALTH SCIENCES  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
A comparative study of 0.5% ropivacaine injection with mixture of 0.5% bupivacaine and 2% lignocaine in peribulbar block in cataract surgery to check the efficacy and safety by recording the intraocular pressure before and after peribulbar block. This study helps prevent complications caused by high intraocular pressure and prolonged motor blockade in cataract surgery and also to know the ideal drug with minimal complications in cataract surgery. 
Close